Difficulty: Medium
Average Score: 83%
Practice
Which of the following hypnotic agents is able to interact with both BZ1 and BZ2 receptor subtypes?
Correct answer
C
Rationale
In pharmacology, understanding the specific receptor interactions of drugs is crucial for predicting their effects. In this case, the correct answer is C) Flurazepam. Flurazepam is a hypnotic agent that can interact with both BZ1 and BZ2 receptor subtypes. This is important because BZ1 receptors are involved in the sedative effects of benzodiazepines, while BZ2 receptors are involved in the anxiolytic effects. By interacting with both receptor subtypes, Flurazepam can produce a combination of sedative and anxiolytic effects, making it an effective hypnotic agent.
Now, let's look at why the other options are incorrect:
A) Zaleplon primarily acts on the BZ1 receptor subtype.
B) Phenobarbital is a barbiturate that acts through GABA receptors, not benzodiazepine receptors.
D) Zolpidem mainly targets the BZ1 receptor subtype, not both BZ1 and BZ2.
Understanding the specific receptor interactions of drugs not only helps in selecting the most appropriate medication for a given condition but also aids in predicting potential side effects and drug interactions. This knowledge is essential for healthcare professionals to make informed decisions when prescribing medications to patients with cardiovascular issues or other conditions requiring pharmacological intervention.
Now, let's look at why the other options are incorrect:
A) Zaleplon primarily acts on the BZ1 receptor subtype.
B) Phenobarbital is a barbiturate that acts through GABA receptors, not benzodiazepine receptors.
D) Zolpidem mainly targets the BZ1 receptor subtype, not both BZ1 and BZ2.
Understanding the specific receptor interactions of drugs not only helps in selecting the most appropriate medication for a given condition but also aids in predicting potential side effects and drug interactions. This knowledge is essential for healthcare professionals to make informed decisions when prescribing medications to patients with cardiovascular issues or other conditions requiring pharmacological intervention.